MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2017$3,224,000
+56.9%
186,346
+0.0%
0.00%0.0%
Q1 2017$2,055,000
-25.1%
186,265
-1.4%
0.00%0.0%
Q4 2016$2,743,000
-43.1%
188,932
-3.7%
0.00%
-50.0%
Q3 2016$4,818,000
+49.6%
196,244
+22.7%
0.00%0.0%
Q2 2016$3,221,000
-41.4%
159,936
-23.5%
0.00%
-33.3%
Q1 2016$5,496,000
-98.8%
208,965
-95.3%
0.00%
-98.7%
Q4 2015$447,890,000
-40.6%
4,406,208
+4.2%
0.24%
-43.4%
Q3 2015$754,581,000
-99.9%
4,230,186
-1.9%
0.42%
-13.3%
Q2 2015$958,048,978,000
-0.6%
4,312,622
-11.2%
0.49%
-0.2%
Q1 2015$964,208,735,000
+22.0%
4,854,540
-12.1%
0.49%
+21.4%
Q4 2014$790,485,401,000
+105777.9%
5,523,621
-2.9%
0.40%
+1.8%
Q3 2014$746,601,000
+2.1%
5,690,564
-1.8%
0.40%
+3.4%
Q2 2014$731,133,000
-99.9%
5,797,126
-1.1%
0.38%
-9.5%
Q1 2014$772,485,174,000
+2.4%
5,859,707
-8.8%
0.42%
-0.2%
Q4 2013$754,116,318,000
+12.1%
6,423,478
-0.3%
0.42%
+1.4%
Q3 2013$672,511,389,000
+21.2%
6,446,002
-0.0%
0.42%
+11.2%
Q2 2013$555,078,358,0006,448,4010.38%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2013
NameSharesValueWeighting ↓
Capital Analysts, LLC 7,350$439,309,0000.18%
GOLDMAN SACHS GROUP INC 2,996,127$179,078,0000.07%
MUFG Americas Holdings Corp 52,285$3,125,0000.06%
Zurcher Kantonalbank (Zurich Cantonalbank) 22,936$1,367,0000.05%
GOLDMAN SACHS GROUP INC 419,100$25,050,0000.01%
AQR Capital Management 35,829$2,141,0000.01%
HSBC HOLDINGS PLC 33,669$2,009,0000.01%
NOMURA HOLDINGS INC 6,000$359,0000.00%
GOLDMAN SACHS GROUP INC 147,000$8,786,0000.00%
HUNTINGTON NATIONAL BANK 1,020$61,0000.00%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders